As the new Director of the Lady Davis Institute, Dr. Stephen Robbins hopes to see the LDI gain even more global prominence.
Dr. Stephen Robbins has been appointed Director of the Lady Davis Institute, effective January 2021.
Dr. Michael Pollak, Director of the Stroll Cancer Prevention Centre at the JGH, has been chosen to serve as one of two leaders of a new Canada-wide team, aimed at translating fundamental research about breast cancer into effective treatment options for patients.
Coming in 2019: an online program for JGH patients with scleroderma, a rare autoimmune disease characterized by hardening of connective tissues. Included are instructional videos and advice on developing a personalized exercise routine and setting realistic goals.
Dental research is playing an increasingly significant role in the Lady Davis Institute, especially in an exploration of pain in and around the joint on either side of the jaw bone—second only to back disorders as a source of chronic pain.
Researchers in the Lady Davis Institute are among investigators from across Canada who will share in new federal funding of $2.5 million for research into various types of dementia, including Alzheimer’s disease.
In the most recent round of funding by the Canadian Institutes of Health Research, Dr. Stéphane Richard received a CIHR Foundation Grant worth $3.5 million over seven years.
A symposium honouring the late Dr. Mark Wainberg on November 2 will become an annual international event on emerging and complex infectious diseases.
Dr. Roderick McInnes, Director of the Lady Davis Institute at the JGH, is being honoured with the 2017 Distinguished Scientist Award by the Canadian Society for Clinical Investigation.